Dr Marion Gruffaz on Muck Rack

Dr Marion Gruffaz

United States
As seen in: American Society for Microbiology (ASM)
Covers:  Longevity science, healthy aging, NAD+ biology, cellular senescence, nutraceuticals, preventive health, inflammation, oxidative stress, supplement quality and transparency, women in science.
Doesn't Cover: Clinical medicine, drug therapy, medical diagnosis, pharmaceutical industry, fitness and exercise science, mental health, weight loss products.

Get in touch with Dr Marion

Contact Dr Marion, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Dr Marion Gruffaz’s Biography

Read Full Bio →

Dr. Marion Gruffaz is a biomedical scientist and the founder of Solensis, a longevity supplement and skincare company built around one straightforward idea: that the science of healthy aging should be accessible to everyone, not just researchers.

Dr. Gruffaz completed her PhD in France before moving to the United States to pursue postdoctoral research at the University of Southern California (USC), where she specialized in cellular biology with a focus on cancer, virology, and inflammation. Tho…

Dr Marion Gruffaz’s Journalist Portfolio

See all →
Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis - PubMed

Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis - PubMed

Discovered in 1994, Kaposi's sarcoma-associated herpesvirus (KSHV) has been associated with four human malign…

View article →
Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-ass...

Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-ass...

Infection by Kaposi's sarcoma-associated herpesvirus (KSHV) is necessary for the development of Kaposi's sarc…

View article →
TLR4-Mediated Inflammation Promotes KSHV-Induced Cellular Transformation and Tumorigenesis by Act...

TLR4-Mediated Inflammation Promotes KSHV-Induced Cellular Transformation and Tumorigenesis by Act...

Toll-like receptors (TLR) are conserved immune sensors mediating antimicrobial and antitumoral responses, but…

View article →
Early inhibition of hepatocyte innate responses by hepatitis B virus - PubMed

Early inhibition of hepatocyte innate responses by hepatitis B virus - PubMed

Our data provide strong evidence that HBV viral particles themselves can readily inhibit host innate immune r…

View article →
Expression and functionality of Toll- and RIG-like receptors in HepaRG cells - PubMed

Expression and functionality of Toll- and RIG-like receptors in HepaRG cells - PubMed

Our results indicate that HepaRG cells express a similar pattern of functional TLR/RLR as compared to PHH, th…

View article →
CRISPR-Cas9 Screening of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Cells Identifies XPO...

CRISPR-Cas9 Screening of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Cells Identifies XPO...

The abnormal proliferation of cancer cells is driven by deregulated oncogenes or tumor suppressors, among whi…

View article →

Articles

CRISPR-Cas9 Screening of Kaposi’s Sarcoma-Associated Herpesvirus-Transformed Cells Identifies XPO1 as a Vulnerable Target of Cancer Cells

|
By Dr Marion Gruffaz, Hongfeng Yuan, Hui Liu, Sangsu Bae
| asm.org
Research Article | Host-Microbe Biology Marion Gruffaz, Hongfeng Yuan, Wen Meng, Hui Liu, Sangsu Bae, Jin-Soo Kim, Chun Lu, Yufei Huang, Shou-Jiang Gao Xiang-Jin Meng, Editor DOI: 10.1128/mBio.00866-19 ABSTRACT The abnormal proliferation of cancer cells is driven by deregulated oncogenes or tumor suppressors, among which the cancer-vulnerable genes are attractive therapeutic targets.
Open in Who Shared Issue with article?

Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi’s Sarcoma-Associated Herpesvirus Latent and Lytic Replications

|
By Dr Marion Gruffaz, Marion Gruffaza, Teresa Rushingc, Qing Liu Michaelb
| American Society for Microbiology (ASM)
Oncogenic Kaposi’s sarcoma-associated herpesvirus (KSHV) is etiologically linked to primary effusion lymphoma (PEL), an aggressive and nontreatable malignancy commonly found in AIDS patients. In this study, we performed a high-throughput screening of 3,731 characterized compounds and identified cytarabine, approved by the FDA for treating numerous types of cancer, as a potent inhibitor of KSHV-induced PEL.
Open in Who Shared Issue with article?

TLR4-Mediated Inflammation Promotes KSHV-Induced Cellular Transformation and Tumorigenesis by Activating the STAT3 Pathway

|
By Dr Marion Gruffaz, Karthik Vasan, Brandon Tan, Shou-Jiang Gao
| cancerres.aacrjournals.org
AbstractToll-like receptors (TLR) are conserved immune sensors mediating antimicrobial and antitumoral responses, but recent evidence implicates them in promoting carcinogenesis in certain cancers. Kaposi sarcoma is caused by infection of Kaposi sarcoma–associated herpesvirus (KSHV) and is characterized by uncontrolled neoangiogenesis and inflammation. Here, we show that TLR4 is upregulated in KSHV-infected spindle tumor cells in human Kaposi sarcoma lesions.
Open in Who Shared Issue with article?
See all 4 articles

Interview

See all →

How is social media changing news?

It makes it easier to reach people and easier to mislead them. The difference usually comes down to whether the person speaking actually knows what they are talking about.

What does it mean to be a journalist?

To ask the questions most people do not think to ask, and then explain the answers to everyone else. That is a genuinely important job, especially in science and health where the gap between what research shows and what the public understands can be enormous.

How do you prefer to be pitched on stories?

Email with context. Tell me what you are working on, what angle you are taking, and what you actually need from me. I am happy to help when I understand what the story is trying to do.
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified